Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country

Eur Respir J. 2017 Jan 3;49(1):1601967. doi: 10.1183/13993003.01967-2016. Print 2017 Jan.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antitubercular Agents / administration & dosage*
  • Communicable Disease Control / standards
  • Drug Administration Schedule*
  • Ethambutol / administration & dosage
  • Female
  • Humans
  • Infectious Disease Medicine / standards
  • Male
  • Mycobacterium tuberculosis
  • Ofloxacin / administration & dosage*
  • Pakistan / epidemiology
  • Pyrazinamide / administration & dosage
  • Streptomycin / administration & dosage
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • World Health Organization
  • Young Adult

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Ethambutol
  • Ofloxacin
  • Streptomycin